Elizabeth Arden (RDEN) 10-Q 1 Nov 13 2014 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Sep. 30, 2013	Oct. 29, 2013
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Entity Registrant Name	'ELIZABETH ARDEN INC	'
Entity Central Index Key	'0000095052	'
Current Fiscal Year End Date	'--06-30	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	29,574,072

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Current Assets	'	'
Cash and cash equivalents	$45,152	$61,674
Accounts receivable, net	337,530	211,763
Inventories	401,860	310,934
Deferred income taxes	35,895	35,850
Prepaid expenses and other assets	38,121	37,458
Total current assets	858,558	657,679
Property and equipment, net	106,815	106,588
Exclusive brand licenses, trademarks and intangibles, net	294,541	296,416
Goodwill	31,607	21,054
Debt financing costs, net	6,193	6,536
Deferred income taxes	4,490	1,442
Other	16,940	14,017
Total assets	1,319,144	1,103,732
Current Liabilities	'	'
Short-term debt	234,200	88,000
Accounts payable - trade	157,845	115,180
Other payables and accrued expenses	121,464	90,179
Total current liabilities	513,509	293,359
Long-term Liabilities	'	'
Long-term debt	250,000	250,000
Deferred income taxes and other liabilities	35,501	45,091
Total long-term liabilities	285,501	295,091
Total liabilities	799,010	588,450
Redeemable noncontrolling interest (See Note 5)	6,912	'
Commitments and contingencies (see Note 10)	'	'
Shareholders' Equity	'	'
Common stock, $.01 par value, 50,000,000 shares authorized; 34,405,674 and 34,338,422 shares issued, respectively	344	343
Additional paid-in capital	349,530	349,060
Retained earnings	259,762	258,065
Treasury stock (4,831,602 and 4,686,094 shares at cost, respectively)	-92,830	-87,776
Accumulated other comprehensive (loss) income	-3,584	-4,410
Total shareholders' equity	513,222	515,282
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$1,319,144	$1,103,732

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Jun. 30, 2013
Consolidated Balance Sheets [Abstract]	'	'
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	34,405,674	34,338,422
Treasury stock, shares at cost	4,831,602	4,686,094

Consolidated_Statements_Of_Inc

Consolidated Statements Of Income (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Consolidated Statements Of Income [Abstract]	'	'
Net sales	$343,609	$344,541
Cost of goods sold:	'	'
Cost of sales	193,674	195,611
Depreciation related to cost of goods sold	1,830	1,531
Total cost of goods sold	195,504	197,142
Gross profit	148,105	147,399
Operating expenses	'	'
Selling, general and administrative	129,372	129,407
Depreciation and amortization	10,699	9,129
Total operating expenses	140,071	138,536
Income from operations	8,034	8,863
Interest expense, net	6,032	6,198
Income before income taxes	2,002	2,665
Provision for income taxes	414	481
Net income	1,588	2,184
Net loss attributable to noncontrolling interests (See Note 5)	-109	'
Net income attributable to Elizabeth Arden shareholders	$1,697	$2,184
Net income per common share attributable to Elizabeth Arden shareholders:	'	'
Basic	$0.06	$0.07
Diluted	$0.06	$0.07
Weighted average number of common shares:	'	'
Basic	29,679	29,417
Diluted	30,288	30,369

Consolidated_Statements_Of_Com

Consolidated Statements Of Comprehensive Income (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013		Sep. 30, 2012
Statement of Comprehensive Income [Abstract]	'		'
Net income	$1,588		$2,184
Other comprehensive income, net of tax:	'		'
Foreign currency translation adjustments	2,193	[1]	1,222	[1]
Net unrealized cash flow hedging loss	-1,367	[2]	-671	[2]
Total other comprehensive income, net of tax	826		551
Comprehensive income	2,414		2,735
Net loss attributable to noncontrolling interests	-109		'
Comprehensive income attributable to Elizabeth Arden shareholders	2,523		2,735
Net unrealized cash flow hedging loss, tax benefit	$189		$178
[1]	Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.
[2]	Net of tax benefits of $189 and $178 for the three months ended September 30, 2013 and September 30, 2012, respectively.

Consolidated_Statement_Of_Shar

Consolidated Statement Of Shareholders' Equity (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
In Thousands
Balance at Jun. 30, 2013	$343	$349,060	$258,065	($87,776)	($4,410)	$515,282
Balance, shares at Jun. 30, 2013	34,338	'	'	-4,686	'	'
Issuance of common stock upon exercise of options, net of tax withholdings of $965	1	-631	'	'	'	-630
Issuance of common stock upon exercise of options, net of tax withholdings of $965, shares	44	'	'	'	'	'
Issuance of restricted stock, net of forfeitures and tax withholdings	'	-1,198	'	'	'	-1,198
Issuance of restricted stock, net of forfeitures and tax withholdings, shares	24	'	'	'	'	'
Amortization of share-based awards	'	1,606	'	'	'	1,606
Repurchase of common stock	'	'	'	-5,054	'	-5,054
Repurchase of common stock, shares	'	'	'	-146	'	'
Excess tax benefit from share-based awards	'	693	'	'	'	693
Net income attributable to Elizabeth Arden shareholders	'	'	1,697	'	'	1,697
Foreign currency translation adjustments	'	'	'	'	2,193	2,193	[1]
Net unrealized cash flow hedging loss	'	'	'	'	-1,367	-1,367	[2]
Balance at Sep. 30, 2013	$344	$349,530	$259,762	($92,830)	($3,584)	$513,222
Balance, shares at Sep. 30, 2013	34,406	'	'	-4,832	'	'
[1]	Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.
[2]	Net of tax benefits of $189 and $178 for the three months ended September 30, 2013 and September 30, 2012, respectively.

Consolidated_Statement_Of_Shar1

Consolidated Statement Of Shareholders' Equity (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
Consolidated Statement Of Shareholders' Equity [Abstract]	'
Issuance of common stock upon exercise of options, tax withholdings	$965

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating activities:	'	'
Net income	$1,588	$2,184
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	12,529	10,660
Amortization of senior note offering and credit facility costs	343	340
Amortization of share-based awards	1,606	1,377
Deferred income taxes	-1,935	-2,811
Change in assets and liabilities, net of acquisitions:	'	'
Increase in accounts receivable	-122,809	-121,212
Increase in inventories	-87,604	-103,693
(Increase) decrease in prepaid expenses and other assets	-1,072	4,020
Increase in accounts payable	44,022	68,558
Increase (decrease) in other payables, accrued expenses and other liabilities	22,647	-982
Other	30	298
Net cash used in operating activities	-130,655	-141,261
Investing activities:	'	'
Additions to property and equipment	-13,884	-8,866
Acquisition of businesses, intangibles and other assets	-3,000	-5,468
Cash received from consolidation of variable interest entity	574	'
Net cash used in investing activities	-16,310	-14,334
Financing activities:	'	'
Proceeds from short-term debt	144,000	124,800
Proceeds from the exercise of stock options	334	3,491
Repurchase of common stock	-5,054	'
Payments of contingent consideration related to acquisition	-4,914	'
Payments to noncontrolling interests	-4,979	'
Excess tax benefit from share-based awards	851	4,032
Payments under capital lease obligations	-5	'
Net cash provided by financing activities	130,233	132,323
Effect of exchange rate changes on cash and cash equivalents	210	109
Net decrease in cash and cash equivalents	-16,522	-23,163
Cash and cash equivalents at beginning of period	61,674	59,080
Cash and cash equivalents at end of period	45,152	35,917
Supplemental Disclosure of Non-Cash Flow Information:	'	'
Additions to property and equipment not paid for (not included above)	$810	$560

Business_And_Basis_Of_Presenta

Business And Basis Of Presentation	3 Months Ended
	Sep. 30, 2013
Business And Basis Of Presentation [Abstract]	'
Business And Basis Of Presentation	'
	NOTE 1. BUSINESS AND BASIS OF PRESENTATION
	Elizabeth Arden, Inc. (the "Company" or "our") is a global prestige beauty products company that sells fragrances, skin care and cosmetic products to retailers in the United States and approximately 120 countries internationally.
	The unaudited consolidated financial statements include the accounts of the Company's wholly-owned domestic and international subsidiaries, as well as a variable interest entity ("VIE") of which the Company is the primarybeneficiary in accordance with consolidation accounting guidance. See Note 5 for information on the consolidated VIE. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the "Commission") for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statement presentation and should be read in conjunction with the audited consolidated financial statements and related footnotes included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2013 (the "2013 Annual Report"), filed with the Commission.
	The consolidated balance sheet of the Company as of June 30, 2013, is derived from the financial statements included in the 2013 Annual Report but does not include all disclosures required by accounting principles generally accepted in the United States. The other consolidated financial statements presented in this quarterly report are unaudited but include all adjustments that are of a normal recurring nature that management considers necessary for the fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of results for the full fiscal year.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	3 Months Ended
	Sep. 30, 2013
Accumulated Other Comprehensive Loss [Abstract]	'
Accumulated Other Comprehensive Loss	'
	NOTE 2. ACCUMULATED OTHER COMPREHENSIVE LOSS
	The Company's accumulated other comprehensive loss shown on the accompanying consolidated balance sheets consists of foreign currency translation adjustments, which are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries, and the unrealized (losses) gains, net of taxes, related to the Company's foreign currency contracts.
	The components of accumulated other comprehensive loss were as follows:
			September 30,			June 30,
	(Amounts in thousands)		2013			2013
	Cumulative foreign currency translation adjustments	$	(2,814	)	$	(5,007	)
	Unrealized hedging (losses) gains, net of taxes (1)		(770	)		597
	Accumulated other comprehensive loss	$	(3,584	)	$	(4,410	)
	(1) Net of tax benefit of $128 as of September 30, 2013 and tax expense of $61 as of June 30, 2013.

Net_Income_Per_Share_Attributa

Net Income Per Share Attributable To Elizabeth Arden Shareholders	3 Months Ended
	Sep. 30, 2013
Net Income Per Share Attributable To Elizabeth Arden Shareholders [Abstract]	'
Net Income Per Share Attributable To Elizabeth Arden Shareholders	'
	NOTE 3. NET INCOME PER SHARE ATTRIBUTABLE TO ELIZABETH ARDEN SHAREHOLDERS
	Basic net income per share attributable to Elizabeth Arden shareholders is computed by dividing the net income attributable to Elizabeth Arden shareholders by the weighted average number of shares of the Company's outstanding common stock, $.01 par value per share ("Common Stock"). The calculation of net income per diluted share attributable to Elizabeth Arden shareholders is similar to basic net income per share attributable to Elizabeth Arden shareholders except that the denominator includes potentially dilutive Common Stock equivalents, such as stock options and non-vested restricted stock or restricted stock units.
	The following table represents the computation of net income per share attributable to Elizabeth Arden shareholders:
	(Amounts in thousands, except per share data)	Three Months Ended
			September 30,		September 30,
			2013		2012
	Basic
	Net income attributable to Elizabeth Arden shareholders	$	1,697	$	2,184
	Weighted average shares outstanding		29,679		29,417
	Net income per basic share attributable to Elizabeth Arden
	shareholders	$	0.06	$	0.07
	Diluted
	Net income attributable to Elizabeth Arden shareholders	$	1,697	$	2,184
	Weighted average shares outstanding		29,679		29,417
	Potential common shares - treasury method		609		952
	Weighted average shares and potential dilutive shares		30,288		30,369
	Net income per diluted share attributable to Elizabeth Arden
	shareholders	$	0.06	$	0.07
	The following table shows the number of Common Stock equivalents for the three months ended September 30, 2013 and 2012 that were not included in the net income per diluted share attributable to Elizabeth Arden shareholders calculation because to do so would have been anti-dilutive:
	(Amounts in thousands)	Three Months Ended
		September 30,	September 30,
		2013	2012
	Number of shares	81	73

Restructuring_Expenses

Restructuring Expenses	3 Months Ended
	Sep. 30, 2013
Restructuring Expenses	'
Restructuring Expenses	'
	NOTE 4. RESTRUCTURING EXPENSES
	In August 2013, the Company announced it expected to incur approximately $5 million in restructuring expenses and related transition costs in fiscal 2014. These restructuring expenses and related transition costs reflect amounts incurred with respect to sales and other positions across various business units that are being eliminated to derive expense savings and additional operating efficiencies. During the three months ended September 30, 2013, the Company incurred restructuring expenses of $1.8 million.
	Aggregate amounts paid during the three months ended September 30, 2013 for restructuring expenses were $0.9 million. All of the restructuring expenses are included in selling, general and administrative expenses in the Company's consolidated statements of income and, as described in Note 15, have not been attributed to any of the Company's reportable segments and are included in unallocated corporate expenses. At September 30, 2013, the Company had a restructuring liability of $0.9 million, that is expected to be paid over the remainder of fiscal 2014.

Investments_And_Noncontrolling

Investments And Noncontrolling Interests	3 Months Ended
	Sep. 30, 2013
Investments And Noncontrolling Interests [Abstract]	'
Investments And Noncontrolling Interests	'
	NOTE 5. INVESTMENTS AND NONCONTROLLING INTERESTS
	On July 2, 2013, the Company, through a subsidiary (the "EA USC Subsidiary"), invested $6.0 million in US Cosmeceutechs, LLC ("USC"), a skin care company that develops and sells skin care products into the professional dermatology and spa channels. The investment, which is in the form of a collateralized convertible note that bears interest at 1.5%, is convertible into 50% of the fully diluted equity interest of USC at any time at the option of the EA USC Subsidiary and also converts automatically upon the satisfaction of certain conditions. As of September 30, 2013, the note had not been converted.
	Under the terms of the operating agreement of USC, the EA USC Subsidiary has control of the board of managers of USC and the power to direct activities that could have a substantial impact on the economic performance of USC, including those that could result in the obligation to absorb losses or the right to receive benefits that could potentially be significant to USC. Based on the investment in USC and EA USC Subsidiary's controlling rights under the operating agreement, the Company has determined that USC is a VIE, of which the Company is the primary beneficiary, requiring consolidation of USC's financial statements in accordance with Topic 810, Consolidation.
	On July 11, 2013, the EA USC Subsidiary purchased a 30% equity interest in USC from the sole equity member (the "Member") for $3.6 million under the terms of a put-call agreement with the USC Member. Under the terms of the put-call agreement, the EA USC Subsidiary has an option to purchase the Member's remaining 20% equity interest in USC at specified prices under certain circumstances based on USC's performance, and similarly the Member has the ability to put its interest in USC to the Company at specified prices under certain circumstances based on USC's performance. Based on the terms of the put-call agreement, it is likely that the EA USC Subsidiary would exercise its call option prior to the Member exercising his put option. In accordance with Topic 480, Distinguishing Liabilities from Equity, the Company is required to classify the noncontrolling interest in USC as a "redeemable noncontrolling interest" in the mezzanine section of the Company's consolidated balance sheet.
	As a result of the agreements with USC and the Member and the requirement to consolidate the financial statements of USC, the Company recorded the following amounts on its consolidated balance sheet on the July 2, 2013 closing date:
	(Amounts in thousands)		Amount
	Inventory	$	2,541
	Other assets		1,577
	Intangible assets (1)		2,873
	Goodwill		10,553
	Current liabilities		(3,698	)
	Long-term liabilities		(1,846	)
	Redeemable noncontrolling interest liability		(12,000	)
	(1) The intangible assets relate to trademarks and other intangibles and are being amortized over an average useful life of approximately 15 years and 10 years, respectively.
	The fair value of USC on the closing date was $12 million. With the exception of the intangible assets and goodwill, the values assigned to the assets and liabilities above were based on their carrying values on the date of investment, which approximated their fair value. In determining the value of the intangible assets and goodwill, the Company considered, among other factors, the intention for future use of any existing intellectual property and any intellectual property currently being developed, as well as the value of the current workforce and its potential to develop future intellectual property to be used in the business. As of the date of investment, there were no significant research and development activities for new intellectual property in progress for use outside of the current portfolio of products. It is expected that certain technology and formulas used in current USC products will be integrated into certain select Elizabeth Arden skin care products in the future. As a result, based on the Company's valuation, the primary value was determined to be related to the current workforce and its potential to develop new intellectual property in the future, which is represented in the goodwill amount above. The goodwill recorded relates to the Company's North America segment and is not deductible for tax purposes. The fair values of the intangible assets and goodwill were calculated primarily using (i) an income approach, and (ii) discount rates which reflect the risk associated with receiving future cash flows.
	The following provides an analysis of the change in the redeemable noncontrolling interest liability for the period ended September 30, 2013:
	(Amounts in thousands)		Amount
	Beginning as of June 30, 2013	$	-
	Amount recorded on closing date		12,000
	Payment to Member for 30% equity interest		(3,600	)
	Payments to noncontrolling interests		(1,379	)
	Net loss attributable to noncontrolling interests		(109	)
	Balance at September 30, 2013	$	6,912
	On July 12, 2013, the Company invested $3 million for a 20% equity interest in a company that is developing a beauty device (the "Device Company"). Under the terms of the equity interest purchase agreement, the Company has an obligation to purchase an additional 20% equity interest at a cost of $6 million upon the achievement of certain milestones related to the development and shipment to customers of a beauty device. In conjunction with the purchase of the equity interest, the Company entered into a license with the Device Company to become the exclusive worldwide manufacturer, marketer and distributor of the beauty device. In addition, the Company also has an option to purchase the remaining 60% equity interest in the Device Company at a specified price under certain circumstances based on the sales performance of the device. The investment has been accounted for using the equity method and at September 30, 2013, is included in other assets on the consolidated balance sheet.

Inventories

Inventories	3 Months Ended
	Sep. 30, 2013
Inventories [Abstract]	'
Inventories	'
	NOTE 6. INVENTORIES
	The components of inventory were as follows:
			September 30,		June 30,
	(Amounts in thousands)		2013		2013
	Raw materials	$	60,602	$	66,295
	Work in progress		27,349		26,902
	Finished goods		313,909		217,737
	Total	$	401,860	$	310,934

Exclusive_Brand_Licenses_Trade

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill	3 Months Ended
	Sep. 30, 2013
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]	'
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill	'
	NOTE 7. EXCLUSIVE BRAND LICENSES, TRADEMARKS AND INTANGIBLES, NET AND GOODWILL
	The following summarizes the cost basis amortization and weighted average estimated life associated with the Company's intangible assets:
								30-Jun-13
			September 30,			June 30,		Weighted Average
	(Amounts in thousands)		2013			2013		Estimated Life
	Elizabeth Arden brand trademarks	$	122,415		$	122,415		Indefinite
	Exclusive brand licenses and related trademarks		179,549			179,506		13
	Exclusive brand trademarks		101,425			100,902		17
	Other intangibles (1)		18,580			16,000		20
	Exclusive brand licenses, trademarks and intangibles, gross		421,969			418,823
	Accumulated amortization:
	Exclusive brand licenses and related trademarks		(72,192	)		(68,508	)
	Exclusive brand trademarks		(49,471	)		(48,398	)
	Other intangibles		(5,765	)		(5,501	)
	Exclusive brand licenses, trademarks and intangibles, net	$	294,541		$	296,416
	(1) Primarily consists of customer relationships, customer lists, non-compete agreements and product formulas.
	At September 30, 2013, the Company had goodwill of $31.6 million recorded on its consolidated balance sheet. The entire amount of the goodwill in all periods presented relates to the North America segment. The amount of goodwill recorded on the consolidated balance sheet at September 30, 2013, increased by $10.5 million as a result of the investment in USC. See Note 5. The Company did not record any impairments during the three months ended September 30, 2013, as there were no events that triggered an impairment analysis.
	Amortization expense was $4.9 million and $4.8 million for the three months ended September 30, 2013 and 2012, respectively. At September 30, 2013, the Company estimated annual amortization expense for each of the next five fiscal years as shown in the following table. Future acquisitions, renewals or impairment events could cause these amounts to change.
			Remainder
	(Amounts in millions)		of 2014		2015		2016		2017		2018
	Amortization expense	$	14.4	$	18.7	$	18	$	16.6	$	16.5

Other_Payables_And_Accrued_Exp

Other Payables And Accrued Expenses	3 Months Ended
	Sep. 30, 2013
Other Payables And Accrued Expenses [Abstract]	'
Other Payables And Accrued Expenses	'
	NOTE 8. OTHER PAYABLES AND ACCRUED EXPENSES
	A summary of the Company's other payables and accrued expenses is as follows:
			September 30,		June 30,
	(Amounts in thousands)		2013		2013
	Accrued advertising, promotion and royalties	$	36,696	$	12,605
	Accrued employee-related benefits		16,972		26,668
	Accrued value added taxes		12,561		6,395
	Accrued interest		1,700		6,200
	Other accruals		53,535		38,311
	Total other payables and accrued expenses	$	121,464	$	90,179

ShortTerm_Debt

Short-Term Debt	3 Months Ended
	Sep. 30, 2013
Short-Term Debt [Abstract]	'
Short-Term Debt	'
	NOTE 9. SHORT-TERM DEBT
	The Company has a $300 million revolving bank credit facility ("the Credit Facility") with a syndicate of banks, for which JPMorgan Chase Bank is the administrative agent, which generally provides for borrowings on a revolving basis, with a sub-limit of $25 million for letters of credit. Under the terms of the Credit Facility, the Company may, at any time, increase the size of the Credit Facility up to $375 million without entering into a formal amendment requiring the consent of all of the banks, subject to the Company's satisfaction of certain conditions. The Credit Facility was amended in June 2012 to allow for the contingent consideration that may become payable with respect to the acquisition of certain assets of Give Back Brands, LLC and to allow for the second lien facility further described below. The credit facility expires in January 2016.
	The Credit Facility is guaranteed by all of the Company's U.S. subsidiaries and is collateralized by a first priority lien on all of the Company's U.S. accounts receivable and inventory. Borrowings under the Credit Facility are limited to 85% of eligible accounts receivable and 85% of the appraised net liquidation value of the Company's inventory, as determined pursuant to the terms of the Credit Facility; provided, however, that from August 15 to October 31 of each year the Company's borrowing base may be temporarily increased by up to $25 million.
	The Credit Facility has only one financial maintenance covenant, which is a debt service coverage ratio that must be maintained at not less than 1.1 to 1 if average borrowing base capacity declines to less than $25 million ($35 million from September 1 through January 31). The Company's average borrowing base capacity for the quarter ended September 30, 2013, did not fall below the applicable thresholds noted above. Accordingly, the debt service coverage ratio did not apply for the quarter ended September 30, 2013.
	Under the terms of the Credit Facility, the Company may pay dividends or repurchase Common Stock if it maintains borrowing base capacity of at least $25 million from February 1 to August 31, and at least $35 million from September 1 to January 31, after making the applicable payment. The Credit Facility restricts the Company from incurring additional non-trade indebtedness (other than refinancings and certain small amounts of indebtedness).
	Borrowings under the credit portion of the Credit Facility bear interest at a floating rate based on an "Applicable Margin" which is determined by reference to a debt service coverage ratio. At the Company's option, the Applicable Margin may be applied to either the London InterBank Offered Rate ("LIBOR") or the base rate (which is comparable to prime rates). The Applicable Margin ranges from 1.75% to 2.50% for LIBOR loans and from 0.25% to 1.0% for base rate loans, except that the Applicable Marginonthefirst$25millionof borrowings from August 15 to October 31 of each year, while the temporary increase in the Company's borrowing base is in effect, is 1.0% higher. The Company is required to pay an unused commitment fee ranging from 0.375% to 0.50% based on the quarterly average unused portion of the Credit Facility.
	At September 30, 2013, the Applicable Margin was 1.75% for LIBOR loans and 0.25% for base rate loans. For the three months ended September 30, 2013 and 2012, the weighted average annual interest rate on borrowings under the Credit Facility was 2.1% and 2.3%, respectively.
	The Company has a second lien credit agreement (the "Second Lien Facility") with JPMorgan Chase Bank, N.A. providing the Company the ability to borrow up to $30 million on a revolving basis. The Second Lien Facility matures on July 2, 2014. The Second Lien Facility is collateralized by a second priority lien on all of the Company's U.S. accounts receivable and inventories and the interest on borrowings charged under the Second Lien Facility is either (i) LIBOR plus an applicable margin of 3.25% or (ii) the base rate specified in the Second Lien Facility (which is comparable to prime rates) plus a margin of 1.75%. The unused commitment fee applicable to the Second Lien Facility ranges from 0.25% to 0.375% based on the quarterly average unused portion of the Second Lien Facility. To the extent the Company borrows amounts under the Second Lien Facility, the Company has the option to prepay all or a portion of such borrowings, provided the borrowing base capacity under the Credit Facility is in excess of $35 million after giving effect to the applicable prepayment each day for the 30 day period ending on the date of the prepayment.
	At September 30, 2013, the Company had $234.2 million in outstanding borrowings and approximately $3.2 million in letters of credit outstanding under the Credit Facility compared with $88.0 million in borrowings and $2.6 million in letters of credit outstanding at June 30, 2013. At both September 30, 2013 and June 30, 2013, the Company had no outstanding borrowings under the Second Lien Facility. At September 30, 2013, based on eligible accounts receivable and inventory available as collateral, an additional $76.8 million in the aggregate could be borrowed under the Credit Facility and the Second Lien Facility. In periods when there are outstanding borrowings, the Company classifies the Credit Facility and Second Lien Facility as short term debt on its balance sheet because it expects to reduce outstanding borrowings over the next twelve months.

Commitments_And_Contingencies

Commitments And Contingencies	3 Months Ended
	Sep. 30, 2013
Commitments And Contingencies [Abstract]	'
Commitments And Contingencies	'
	NOTE 10. COMMITMENTS AND CONTINGENCIES
	In connection with the acquisition of global licenses and certain assets from Give Back Brands LLC in June 2012, the Company agreed to pay Give Back Brands LLC up to an additional $28 million subject to the achievement of specified sales targets for the acquired brands over a three-year period from July 1, 2012 through June 30, 2015. As part of the accounting for the acquisition, the Company established a liability for the potential payment of $28 million based upon the probability of achieving the specified sales targets. Based on results for fiscal 2013, conditions for the payment of the first and second $5 million installments were satisfied, and such installments were paid during the third quarter of fiscal 2013 and first quarter of fiscal 2014, respectively.
	During fiscal 2013, the Company invested $7.6 million, including transaction costs, for a minority investment in Elizabeth Arden Salon Holdings, LLC, an unrelated party whose subsidiaries operate the Elizabeth Arden Red Door Spas and the Mario Tricoci Hair Salons ("Salon Holdings"). The investment, which is in the form of a collateralized convertible note bearing interest at 2%, has been accounted for using the cost method and at September 30, 2013, is included in other assets on the consolidated balance sheet. The Company expects to invest an additional $2.1 million in fiscal 2014. The Company entered into a co-investment agreement with another minority investor of Salon Holdings under which the minority investor has the ability to put its interest in Salon Holdings to the Company under certain circumstances, at a specified price based on the performance of Salon Holdings over the previous 12 month period. Should the minority investor put its interest in Salon Holdings to the Company, it can elect to receive payment in cash, Common Stock or a combination of both. As of September 30, 2013, if the minority investor had put its interest in Salon Holdings to the Company, based on the performance of Salon Holdings over the previous 12 month period, the impact would not have been material to the Company's liquidity.
	The Company is a party to a number of legal actions, proceedings, audits, tax audits, claims and disputes, arising in the ordinary course of business, including those with current and former customers over amounts owed. While any action, proceeding, audit or claim contains an element of uncertainty and may materially affect the Company's cash flows and results of operations in a particular quarter or year, based on current facts and circumstances, the Company's management believes that the outcome of such actions, proceedings, audits, claims and disputes will not have a material adverse effect on the Company's business, prospects, results of operations, financial condition or cash flows.
	The Company and its domestic subsidiaries file income tax returns with federal, state and local tax authorities within the United States. The Company also files tax returns for its international affiliates in various foreign jurisdictions. The statute of limitations for the Company's U.S. federal tax returns remains open for the year ended June 30, 2008 and subsequent fiscal years. The Internal Revenue Service ("IRS") began an examination of the Company's U.S. federal tax returns for fiscal 2008 and fiscal 2009 during fiscal year 2011 and, in May 2013 issued an IRS Letter 950 ("30-day Letter") for fiscal 2008 and fiscal 2009 relating to transfer pricing matters. In the 30-day Letter, the IRS proposed adjustments that would increase the Company's U.S. taxable income for fiscal 2008 and fiscal 2009 by approximately $29.1 million, which could be material to the Company's consolidated statements of operations in the period in which resolved unless resolved favorably by the Company. The Company disagrees with the proposed adjustments and has filed a protest commencing the appeals process and intends to vigorously contest them and pursue its available remedies. While any IRS examination contains an element of uncertainty, based on current facts and circumstances, the Company believes the ultimate outcome at IRS appeals or any judicial process, if necessary, will not have a material adverse effect on the Company's financial condition, business or prospects. In addition, if the examination is not resolved favorably, the Company has $105 million of U.S. federal operating loss carryforwards as of June 30, 2013, of which $60 million would be available to offset any cash flow impact. It is reasonably possible that over the next twelvemonth period the Company may experience an increase or decrease in its unrecognized tax benefits, but it is not possible to determine either the magnitude or range of any increase or decrease at this time. During the first quarter of fiscal 2014, the Company received notice from the IRS that in October 2013 they will begin an examination of the Company's U.S. federal tax returns for fiscal 2010, fiscal 2011 and fiscal 2012. The year ended June 30, 2004 and subsequent fiscal years remain subject to examination for various state tax jurisdictions. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations generally ranging from one to five years. The year ended June 30, 2008 and subsequent fiscal years remain subject to examination for various foreign jurisdictions.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Sep. 30, 2013
Fair Value Measurements [Abstract]	'
Fair Value Measurements	'
	NOTE 11. FAIR VALUE MEASUREMENTS
	Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The accounting standards also have established a fair value hierarchy, which prioritizes the inputs to valuation techniques used in measuring fair value into three broad levels as follows:
	Level 1 - Quoted prices in active markets for identical assets or liabilities
	Level 2 - Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly Level 3 - Unobservable inputs based on the Company's own assumptions
	The Company's long-term debt consists of $250 million aggregate principal amount of its 7 3/8% Senior Notes due 2021 (the "7 3/8% Senior Notes"). At September 30, 2013 and June 30, 2013, the estimated fair value of the 7 3/8% Senior Notes was as follows:
			September 30,		June 30,
	(Amounts in thousands)		2013		2013
	7 3/8% Senior Notes due March 2021 (Level 2)	$	270,000	$	271,250
	The Company determined the estimated fair value amounts by using available market information and commonly accepted valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value, primarily due to the illiquid nature of the capital markets in which the 7 3/8% Senior Notes are traded. The use of different assumptions and/or estimation methodologies may have a material effect on the estimated fair value.
	The Company's derivative assets and liabilities are currently composed of foreign currency contracts. Fair values are based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions.
	The following table presents the fair value hierarchy for the Company's financial assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2013 and June 30, 2013:
	(Amounts in thousands)		30-Sep-13				30-Jun-13
			Asset		Liability		Asset		Liability
	Level 2	$	523	$	1,421	$	658	$	--
	Total	$	523	$	1,421	$	658	$	--
	See Note 12 for a discussion of the Company's foreign currency contracts.
	Accounting standards require non-financial assets and liabilities to be recognized at fair value subsequent to initial recognition when they are deemed to be other-than-temporarily impaired. As of September 30, 2013, the Company did not have any non-financial assets and liabilities measured at fair value.

Derivative_Financial_Instrumen

Derivative Financial Instruments	3 Months Ended
	Sep. 30, 2013
Derivative Financial Instruments [Abstract]	'
Derivative Financial Instruments	'
	NOTE 12. DERIVATIVE FINANCIAL INSTRUMENTS
	The Company operates in several foreign countries, which exposes it to market risk associated with foreign currency exchange rate fluctuations. The Company's risk management policy is to enter into cash flow hedges to reduce a portion of the exposure of the Company's foreign subsidiaries' revenues to fluctuations in currency rates using foreign currency forward contracts. The Company also enters into cash flow hedges for a portion of its forecasted inventory purchases to reduce the exposure of its foreign subsidiaries' cost of sales to such fluctuations, as well as cash flow hedges for a portion of its subsidiaries' forecasted operating costs. The principal currencies hedged are British pounds, Euros, Canadian dollars, Australian dollars and Swiss francs. The Company does not enter into derivative financial contracts for speculative or trading purposes. The Company's derivative financial instruments are recorded in the consolidated balance sheets at fair value determined using pricing models based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions. Cash flows from derivative financial instruments are classified as cash flows from operating activities in the consolidated statements of cash flows.
	Foreign currency contracts used to hedge forecasted revenues are designated as cash flow hedges. These contracts are used to hedge forecasted revenues generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income within shareholders' equity to the extent such contracts are effective, and are recognized in net sales in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three months ended September 30, 2013 or in fiscal 2013 relating to foreign currency contracts used to hedge forecasted revenues resulting from hedge ineffectiveness. As of September 30, 2013, the Company had notional amounts of 20.3 million British pounds and 19.3 million Euros under foreign currency contracts used to hedge forecasted revenues that expire between October 31, 2013 and May 31, 2015.
	Foreign currency contracts used to hedge forecasted cost of sales or operating costs are designated as cash flow hedges. These contracts are used to hedge the forecasted cost of sales of the Company's Canadian and Australian subsidiaries or operating costs of the Company's Swiss subsidiaries, generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income within shareholders' equity, to the extent such contracts are effective, and are recognized in cost of sales or selling, general and administrative expenses in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three months ended September 30, 2013 or in fiscal 2013 relating to foreign currency contracts used to hedge forecasted cost of sales or forecasted operating costs resulting from hedge ineffectiveness. As of September 30, 2013, the Company had notional amounts under foreign currency contracts of (i) 4.6 million Canadian dollars and 12.1 million Australian dollars used to hedge forecasted cost of sales, and (ii) 9.6 million Swiss francs to hedge forecasted operating costs that expire between October 31, 2013 and May 31, 2014.
	When appropriate, the Company also enters into and settles foreign currency contracts for Euros, British pounds, Canadian dollars and Australian dollars to reduce exposure of the Company's foreign subsidiaries' balance sheets to fluctuations in foreign currency rates. These contracts are used to hedge balance sheet exposure generally over one month and are settled before the end of the month in which they are entered into. Changes to fair value of these forward contracts are recognized in selling, general and administrative expense in the period in which the contracts expire. For the three months ended September 30, 2013 and 2012, the Company recorded losses of $0.7 and $0.5 million, respectively in selling, general and administrative expenses related to these contracts. As of September 30, 2013, there were no such foreign currency contracts outstanding. There were no amounts recorded in the three months ended September 30, 2013 or in fiscal 2013 relating to foreign currency contracts to hedge subsidiary balance sheets resulting from hedge ineffectiveness.
	The following tables illustrate the fair value of outstanding foreign currency contracts and the gains (losses) associated with the settlement of these contracts:
		Fair Value of Derivative
		Instruments Designated as
	(Amounts in thousands)	Effective Hedges
			September 30,		June 30,
	Balance Sheet Location		2013		2013
	Other assets	$	523	$	658
	Other payables	$	1,421	$	-
	Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income, Net of Tax (Effective Portion)
	(Amounts in thousands)	Three Months Ended
			September 30,		September 30,
			2013		2012
	Currency Contracts – Sales (1)	$	56	$	(3	)
	Currency Contracts - Cost of Sales (2)		7		(96	)
	Currency Contracts - Selling, General and
	Administrative Expenses (3)		37		(53	)
	Total (4)	$	100	$	(152	)
	(1) Recorded in net sales on the consolidated statements of income.
	(2) Recorded in cost of sales on the consolidated statements of income.
	(3) Recorded in selling, general and administrative expenses on consolidated statements of income.
	(4) Net of tax expense of $13 for the three months ended September 30, 2013 and tax benefit of $47 for the three months ended September 30, 2012.
	Net Loss Recognized in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)
	(Amounts in thousands)	Three Months Ended
			September 30,			September 30,
			2013			2012
	Currency Contracts - Sales	$	(1,685	)	$	(680	)
	Currency Contracts - Cost of Sales		(101	)		(283	)
	Currency Contracts - Selling, General and
	Administrative Expenses		319			444
	Total (1)	$	(1,467	)	$	(519	)
	(1) Net of tax benefits of $202 and $131 for the three months ended September 30, 2013 and 2012, respectively.

Repurchases_Of_Common_Stock

Repurchases Of Common Stock	3 Months Ended
	Sep. 30, 2013
Repurchases Of Common Stock [Abstract]	'
Repurchases Of Common Stock	'
	NOTE 13. REPURCHASES OF COMMON STOCK
	The Company has an existing stock repurchase program pursuant to which the Company's board of directors has authorized the repurchase of $120 million of Common Stock and that is currently scheduled to expire on November 30, 2014.
	During the three months ended September 30, 2013, the Company purchased 145,508 shares of common stock on the open market under the stock repurchase program at an average price of $34.74 per share and at a cost of $5.1 million, including sales commissions. As of September 30, 2013, the Company has repurchased 4,507,603 shares of common stock on the open market under the stock repurchase program since its inception in November 2005, at an average price of $18.85 per share and at a cost of approximately $85.0 million, including sales commissions, leaving approximately $35.0 million available for additional repurchases under the program. The acquisition of these shares by the Company was accounted for under the treasury method.

New_Accounting_Standards_And_N

New Accounting Standards And New Tax Legislation	3 Months Ended
	Sep. 30, 2013
New Accounting Standards And New Tax Legislation [Abstract]	'
New Accounting Standards And New Tax Legislation	'
	NOTE 14. NEW ACCOUNTING STANDARDS AND NEW TAX LEGISLATION
	In July 2013, the Financial Accounting Standards Board ("FASB") issued an update to Topic 740, Income Taxes. This update requires companies to present an unrecognized tax benefit ("UTB") as a reduction to a deferred tax asset for a net operating loss carryforward , a similar tax loss, or a tax credit carryforward in the applicable jurisdiction, to the extent such tax attributes are available to offset the additional tax liability that would result if the UTB were disallowed on the balance sheet date. Whether the settlement by use of carryforwards is available under the law would depend on facts and circumstances available on the balance sheet date. The new guidance is effective for the Company beginning July 1, 2014, and adoption is not expected to have a material impact on the Company's consolidated financial statements.
	In September 2013, the IRS released final tangible property regulations ("repair regulations") under Sections 162(a) and 263(a) of the Internal Revenue Code, regarding the deduction and capitalization of amounts paid to acquire, produce, or improve tangible property. The final regulations replace temporary regulations that were issued in December 2011 and are effective for tax years beginning January 1, 2014, with early adoption permitted to tax years beginning January 1, 2012. The final regulations are effective for the Company for its tax year beginning July 1, 2014, and the Company is currently evaluating the impact of the final repair regulations on its consolidated financial statements.

Segment_Data_And_Related_Infor

Segment Data And Related Information	3 Months Ended
	Sep. 30, 2013
Segment Data And Related Information [Abstract]	'
Segment Data And Related Information	'
	NOTE 15. SEGMENT DATA AND RELATED INFORMATION
	Reportable operating segments, as defined by Codification Topic 280, Segment Reporting, include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the "Chief Executive") in deciding how to allocate resources and in assessing performance. As a result of the similarities in the procurement, marketing and distribution processes for all of the Company's products, much of the information provided in the consolidated financial statements is similar to, or the same as, that reviewed on a regular basis by the Chief Executive.
	At September 30, 2013, the Company's operations were organized into the following two operating segments, which also comprise its reportable segments:
	— North America - The North America segment sells the Company's portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to department stores, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes the Company's direct to consumer business, which is composed of the Elizabeth Arden branded retail outlet stores and the Company's global e-commerce business. This segment also sells the Elizabeth Arden products through the Red Door beauty salons and spas, which are owned and operated by a third party licensee in which the Company has a minority investment.
	· International - The International segment sells a portfolio of owned and licensed brands, including Elizabeth Arden products, to perfumeries, boutiques, department stores, travel retail outlets and distributors in approximately 120 countries outside of North America.
	The Chief Executive evaluates segment profit based upon income from operations, which represents earnings before income taxes, interest expense and depreciation and amortization charges. The accounting policies for each of the reportable segments are the same as those described in the Company's 2013 Annual Report under Note 1 -- "General Information and Summary of Significant Accounting Policies."
	The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information regarding assets and liabilities of the Company's reportable segments is produced for the Chief Executive or included herein.
	Segment profit excludes depreciation and amortization, interest expense, debt extinguishment charges, consolidation and elimination adjustments and unallocated corporate expenses, which are shown in the table reconciling segment profit to consolidated income before income taxes. Included in unallocated corporate expenses are (i) restructuring charges that are related to an announced plan, (ii) restructuring costs for corporate operations, and (iii) acquisition-related costs, including transition costs. These expenses are recorded in unallocated corporate expenses as these items are centrally directed and controlled and are not included in internal measures of segment operating performance. The Company does not have any intersegment sales.
	The following table is a comparative summary of the Company's net sales and segment profit (loss) by operating segment for the three months ended September 30, 2013 and 2012
	(Amounts in thousands)		Three Months Ended
			September 30,			September 30,
			2013			2012
	Segment Net Sales:
	North America	$	224,659		$	231,557
	International		118,950			112,984
	Total	$	343,609		$	344,541
	Segment Profit (Loss):
	North America	$	28,887		$	36,808
	International		(7,942	)		(5,238	)
	Total	$	20,945		$	31,570
	Reconciliation:
	Segment Profit	$	20,945		$	31,570
	Less:
	Depreciation and Amortization		12,529			10,660
	Interest Expense, net		6,032			6,198
	Consolidation and Elimination Adjustments		(1,993	)		453
	Unallocated Corporate Expenses		2,375	-1		11,594	-2
	Income Before Income Taxes	$	2,002		$	2,665
	(1) Amounts for the three months ended September 30, 2013, include $1.8 million of restructuring expenses and $0.6 million of related transition costs incurred with respect to sales and other positions across various business units that are being eliminated to derive expense savings and additional operating efficiencies.
	(2) Amounts for the three months ended September 30, 2012, include $11.6 million of inventory–related costs primarily for inventory purchased by the Company from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition expenses.

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Sep. 30, 2013
Accumulated Other Comprehensive Loss [Abstract]	'
Schedule Of Accumulated Other Comprehensive Loss	'
			September 30,			June 30,
	(Amounts in thousands)		2013			2013
	Cumulative foreign currency translation adjustments	$	(2,814	)	$	(5,007	)
	Unrealized hedging (losses) gains, net of taxes (1)		(770	)		597
	Accumulated other comprehensive loss	$	(3,584	)	$	(4,410	)
	(1) Net of tax benefit of $128 as of September 30, 2013 and tax expense of $61 as of June 30, 2013.

Net_Income_Per_Share_Attributa1

Net Income Per Share Attributable To Elizabeth Arden Shareholders (Tables)	3 Months Ended
	Sep. 30, 2013
Net Income Per Share Attributable To Elizabeth Arden Shareholders [Abstract]	'
Schedule of Earnings Per Share, Basic And Diluted	'
	(Amounts in thousands, except per share data)	Three Months Ended
			September 30,		September 30,
			2013		2012
	Basic
	Net income attributable to Elizabeth Arden shareholders	$	1,697	$	2,184
	Weighted average shares outstanding		29,679		29,417
	Net income per basic share attributable to Elizabeth Arden
	shareholders	$	0.06	$	0.07
	Diluted
	Net income attributable to Elizabeth Arden shareholders	$	1,697	$	2,184
	Weighted average shares outstanding		29,679		29,417
	Potential common shares - treasury method		609		952
	Weighted average shares and potential dilutive shares		30,288		30,369
	Net income per diluted share attributable to Elizabeth Arden
	shareholders	$	0.06	$	0.07
Schedule Of Common Stock Options, Restricted Stock, And Restricted Stock Unit Awards Outstanding Not Included In Net Income Per Diluted Share	'
	(Amounts in thousands)	Three Months Ended
		September 30,	September 30,
		2013	2012
	Number of shares	81	73

Investments_And_Noncontrolling1

Investments And Noncontrolling Interests (Tables)	3 Months Ended
	Sep. 30, 2013
Investments And Noncontrolling Interests [Abstract]	'
Redeemable Noncontrolling Interest Amounts Recorded On Consolidated Balance Sheet	'
	(Amounts in thousands)		Amount
	Inventory	$	2,541
	Other assets		1,577
	Intangible assets (1)		2,873
	Goodwill		10,553
	Current liabilities		(3,698	)
	Long-term liabilities		(1,846	)
	Redeemable noncontrolling interest liability		(12,000	)
	(1) The intangible assets relate to trademarks and other intangibles and are being amortized over an average useful life of approximately 15 years and 10 years, respectively.
Schedule Of Change In Redeemable Noncontrolling Interest Liability	'
	(Amounts in thousands)		Amount
	Beginning as of June 30, 2013	$	-
	Amount recorded on closing date		12,000
	Payment to Member for 30% equity interest		(3,600	)
	Payments to noncontrolling interests		(1,379	)
	Net loss attributable to noncontrolling interests		(109	)
	Balance at September 30, 2013	$	6,912

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Sep. 30, 2013
Inventories [Abstract]	'
Summary Of Inventory	'
			September 30,		June 30,
	(Amounts in thousands)		2013		2013
	Raw materials	$	60,602	$	66,295
	Work in progress		27,349		26,902
	Finished goods		313,909		217,737
	Total	$	401,860	$	310,934

Exclusive_Brand_Licenses_Trade1

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Tables)	3 Months Ended
	Sep. 30, 2013
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]	'
Summary Of Intangible Assets	'
								30-Jun-13
			September 30,			June 30,		Weighted Average
	(Amounts in thousands)		2013			2013		Estimated Life
	Elizabeth Arden brand trademarks	$	122,415		$	122,415		Indefinite
	Exclusive brand licenses and related trademarks		179,549			179,506		13
	Exclusive brand trademarks		101,425			100,902		17
	Other intangibles (1)		18,580			16,000		20
	Exclusive brand licenses, trademarks and intangibles, gross		421,969			418,823
	Accumulated amortization:
	Exclusive brand licenses and related trademarks		(72,192	)		(68,508	)
	Exclusive brand trademarks		(49,471	)		(48,398	)
	Other intangibles		(5,765	)		(5,501	)
	Exclusive brand licenses, trademarks and intangibles, net	$	294,541		$	296,416
	(1) Primarily consists of customer relationships, customer lists, non-compete agreements and product formulas.
Schedule Of Expected Amortization Expense	'
			Remainder
	(Amounts in millions)		of 2014		2015		2016		2017		2018
	Amortization expense	$	14.4	$	18.7	$	18	$	16.6	$	16.5

Other_Payables_And_Accrued_Exp1

Other Payables And Accrued Expenses (Tables)	3 Months Ended
	Sep. 30, 2013
Other Payables And Accrued Expenses [Abstract]	'
Summary Of Other Payables And Accrued Expenses	'
			September 30,		June 30,
	(Amounts in thousands)		2013		2013
	Accrued advertising, promotion and royalties	$	36,696	$	12,605
	Accrued employee-related benefits		16,972		26,668
	Accrued value added taxes		12,561		6,395
	Accrued interest		1,700		6,200
	Other accruals		53,535		38,311
	Total other payables and accrued expenses	$	121,464	$	90,179

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	3 Months Ended
	Sep. 30, 2013
Fair Value Measurements [Abstract]	'
Schedule Of Estimated Fair Values Of Long Term Debt	'
			September 30,		June 30,
	(Amounts in thousands)		2013		2013
	7 3/8% Senior Notes due March 2021 (Level 2)	$	270,000	$	271,250
Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis	'
	(Amounts in thousands)		30-Sep-13				30-Jun-13
			Asset		Liability		Asset		Liability
	Level 2	$	523	$	1,421	$	658	$	--
	Total	$	523	$	1,421	$	658	$	--

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	3 Months Ended
	Sep. 30, 2013
Derivative Financial Instruments [Abstract]	'
Schedule Of Foreign Exchange Contracts And The Gains (Losses) Associated With The Settlement Of Contracts	'
		Fair Value of Derivative
		Instruments Designated as
	(Amounts in thousands)	Effective Hedges
			September 30,		June 30,
	Balance Sheet Location		2013		2013
	Other assets	$	523	$	658
	Other payables	$	1,421	$	-
Gain (Loss) Reclassified From Accumulated Other Comprehensive Income Into Income, Effective Portion	'
	(Amounts in thousands)	Three Months Ended
			September 30,		September 30,
			2013		2012
	Currency Contracts – Sales (1)	$	56	$	(3	)
	Currency Contracts - Cost of Sales (2)		7		(96	)
	Currency Contracts - Selling, General and
	Administrative Expenses (3)		37		(53	)
	Total (4)	$	100	$	(152	)
	(1) Recorded in net sales on the consolidated statements of income.
	(2) Recorded in cost of sales on the consolidated statements of income.
	(3) Recorded in selling, general and administrative expenses on consolidated statements of income.
	(4) Net of tax expense of $13 for the three months ended September 30, 2013 and tax benefit of $47 for the three months ended September 30, 2012.
Net Loss Recognized On Derivatives In Other Comprehensive Income, Net Of Tax, Effective Portion	'
	(Amounts in thousands)	Three Months Ended
			September 30,			September 30,
			2013			2012
	Currency Contracts - Sales	$	(1,685	)	$	(680	)
	Currency Contracts - Cost of Sales		(101	)		(283	)
	Currency Contracts - Selling, General and
	Administrative Expenses		319			444
	Total (1)	$	(1,467	)	$	(519	)
	(1) Net of tax benefits of $202 and $131 for the three months ended September 30, 2013 and 2012, respectively.

Segment_Data_And_Related_Infor1

Segment Data And Related Information (Tables)	3 Months Ended
	Sep. 30, 2013
Segment Data And Related Information [Abstract]	'
Comparative Summary Of Net Sales And Segment Profit (Loss) By Operating Segment	'
	(Amounts in thousands)		Three Months Ended
			September 30,			September 30,
			2013			2012
	Segment Net Sales:
	North America	$	224,659		$	231,557
	International		118,950			112,984
	Total	$	343,609		$	344,541
	Segment Profit (Loss):
	North America	$	28,887		$	36,808
	International		(7,942	)		(5,238	)
	Total	$	20,945		$	31,570
	Reconciliation:
	Segment Profit	$	20,945		$	31,570
	Less:
	Depreciation and Amortization		12,529			10,660
	Interest Expense, net		6,032			6,198
	Consolidation and Elimination Adjustments		(1,993	)		453
	Unallocated Corporate Expenses		2,375	-1		11,594	-2
	Income Before Income Taxes	$	2,002		$	2,665
	(1) Amounts for the three months ended September 30, 2013, include $1.8 million of restructuring expenses and $0.6 million of related transition costs incurred with respect to sales and other positions across various business units that are being eliminated to derive expense savings and additional operating efficiencies.
	(2) Amounts for the three months ended September 30, 2012, include $11.6 million of inventory–related costs primarily for inventory purchased by the Company from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition expenses.

Business_And_Basis_Of_Presenta1

Business And Basis Of Presentation (Narrative) (Details) (International [Member])	Sep. 30, 2013
	country
International [Member]	'
Business And Basis Of Presentation [Line Items]	'
Number of countries company operates in	120

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss (Details) (USD $)	Sep. 30, 2013		Jun. 30, 2013
In Thousands, unless otherwise specified
Accumulated Other Comprehensive Loss [Abstract]	'		'
Cumulative foreign currency translation adjustments	($2,814)		($5,007)
Unrealized hedging (losses) gains, net of taxes	-770	[1]	597	[1]
Accumulated other comprehensive loss	-3,584		-4,410
Net unrealized hedging gains, tax expense (benefit)	($128)		$61
[1]	Net of tax benefit of $128 as of September 30, 2013 and tax expense of $61 as of June 30, 2013.

Net_Income_Per_Share_Attributa2

Net Income Per Share Attributabel To Elizabeth Arden Shareholders (Schedule of Earnings Per Share, Basic And Diluted) (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Jun. 30, 2013
Net Income Per Share Attributable To Elizabeth Arden Shareholders [Abstract]	'	'	'
Common stock, par value	$0.01	'	$0.01
Net income attributable to Elizabeth Arden shareholders	$1,697	$2,184	'
Weighted average shares outstanding	29,679	29,417	'
Net income per basic share attributable to Elizabeth Arden shareholders	$0.06	$0.07	'
Potential common shares - treasury method	609	952	'
Weighted average shares and potential dilutive shares	30,288	30,369	'
Net income per diluted share attributable to Elizabeth Arden shareholders	$0.06	$0.07	'

Net_Income_Per_Share_Attributa3

Net Income Per Share Attributable To Elizabeth Arden Shareholders (Schedule Of Common Stock Options, Restricted Stock, And Restricted Stock Unit Awards Outstanding Not Included In Net Income Per Diluted Share) (Details)	3 Months Ended	12 Months Ended
	Sep. 30, 2013	Jun. 30, 2013
Net Income Per Share Attributable To Elizabeth Arden Shareholders [Abstract]	'	'
Number of shares	81	73

Restructuring_Expenses_Details

Restructuring Expenses (Details) (USD $)	1 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Aug. 31, 2013	Sep. 30, 2013
Restructuring Expenses	'	'
Expected restructuring expenses and related transition costs	$5	'
Restructuring Charges	'	1.8
Aggregate amounts paid for restructuring expenses	'	0.9
Restructuring liability	'	$0.90

Investments_And_Noncontrolling2

Investments And Noncontrolling Interests (Narrative) (Details) (USD $)	Sep. 30, 2013	Jul. 02, 2013	Sep. 30, 2013	Jul. 12, 2013	Sep. 30, 2013	Jul. 11, 2013
	US Cosmeceutechs, LLC [Member]	US Cosmeceutechs, LLC [Member]	Device Company [Member]	Device Company [Member]	EA USC Subsidiary [Member]	EA USC Subsidiary [Member]
					US Cosmeceutechs, LLC [Member]	US Cosmeceutechs, LLC [Member]
Schedule of Equity Method Investments [Line Items]	'	'	'	'	'	'
Amount of investment	($3,600,000)	$6,000,000	'	$3,000,000	'	$3,600,000
Collateralized convertible note, interest rate	'	1.50%	'	'	'	'
Percentage of fully diluted equity interest, investment can convert to	'	50.00%	'	'	'	'
Percentage of equity interest purchased	30.00%	'	'	20.00%	'	30.00%
Remaining equity interest available to be purchased	'	'	'	'	20.00%	'
Fair value of investment on the closing date	12,000,000	12,000,000	'	'	'	'
Additional equity interest obligated to purchase	'	'	20.00%	'	'	'
Cost of additional equity interest obligated to purchase	'	'	$6,000,000	'	'	'
Remaining equity interest available to purchase	'	'	60.00%	'	'	'

Investments_And_Noncontrolling3

Investments And Noncontrolling Interests (Redeemable Noncontrolling Interest Amounts Recorded On Consolidated Balance Sheet) (Details) (USD $)	12 Months Ended					0 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2013		Sep. 30, 2013	Jul. 02, 2013		Jul. 02, 2013	Jul. 02, 2013
	Other Intangibles [Member]		US Cosmeceutechs, LLC [Member]	US Cosmeceutechs, LLC [Member]		US Cosmeceutechs, LLC [Member]	US Cosmeceutechs, LLC [Member]
						Trademarks [Member]	Other Intangibles [Member]
Schedule of Equity Method Investments [Line Items]	'		'	'		'	'
Inventory	'		'	$2,541		'	'
Other assets	'		'	1,577		'	'
Intangible assets	'		'	2,873	[1]	'	'
Goodwill	'		10,500	10,553		'	'
Current liabilities	'		'	-3,698		'	'
Long-term liabilities	'		'	-1,846		'	'
Redeemable noncontrolling interest liability	'		'	($12,000)		'	'
Average useful life	'20 years	[2]	'	'		'15 years	'10 years
[1]	The intangible assets relate to trademarks and other intangibles and are being amortized over an average useful life of approximately 15 years and 10 years, respectively.
[2]	Primarily consists of customer relationships, customer lists, non-compete agreements and product formulas.

Investments_And_Noncontrolling4

Investments And Noncontrolling Interests (Schedule Of Change In Redeemable Noncontrolling Interest Liability) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Jul. 02, 2013
Schedule of Equity Method Investments [Line Items]	'	'
Payments to noncontrolling interests	$4,979	'
Net loss attributable to noncontrolling interests	-109	'
Balance at September 30, 2013	6,912	'
US Cosmeceutechs, LLC [Member]	'	'
Schedule of Equity Method Investments [Line Items]	'	'
Amount recorded on closing date	12,000	12,000
Payment to Member for 30% equity interest	-3,600	6,000
Payments to noncontrolling interests	-1,379	'
Net loss attributable to noncontrolling interests	-109	'
Balance at September 30, 2013	$6,912	'
Percentage of equity interest purchased	30.00%	'

Inventories_Details

Inventories (Details) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Inventories [Abstract]	'	'
Raw materials	$60,602	$66,295
Work in progress	27,349	26,902
Finished goods	313,909	217,737
Total	$401,860	$310,934

Exclusive_Brand_Licenses_Trade2

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Narrative) (Details) (USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Jun. 30, 2013	Sep. 30, 2013	Jul. 02, 2013
				US Cosmeceutechs, LLC [Member]	US Cosmeceutechs, LLC [Member]
Business Acquisition [Line Items]	'	'	'	'	'
Goodwill	$31,607,000	'	$21,054,000	'	'
Increase in goodwill as a result of investment	'	'	'	10,500,000	10,553,000
Amortization expense	$4,900,000	$4,800,000	'	'	'

Exclusive_Brand_Licenses_Trade3

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Summary Of Intangible Assets) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2013		Sep. 30, 2013
Finite Lived And Indefinite Lived Intangible Assets [Line Items]	'		'
Elizabeth Arden brand trademarks	$122,415		$122,415
Exclusive brand licenses, trademarks and intangibles, gross	418,823		421,969
Exclusive brand licenses, trademarks and intangibles, net	296,416		294,541
Exclusive Brand Licenses And Related Trademarks [Member]	'		'
Finite Lived And Indefinite Lived Intangible Assets [Line Items]	'		'
Elizabeth Arden brand trademarks	179,506		179,549
Weighted Average Estimated Life	'13 years		'
Accumulated amortization	-68,508		-72,192
Exclusive Brand Trademarks [Member]	'		'
Finite Lived And Indefinite Lived Intangible Assets [Line Items]	'		'
Elizabeth Arden brand trademarks	100,902		101,425
Weighted Average Estimated Life	'17 years		'
Accumulated amortization	-48,398		-49,471
Other Intangibles [Member]	'		'
Finite Lived And Indefinite Lived Intangible Assets [Line Items]	'		'
Elizabeth Arden brand trademarks	16,000	[1]	18,580	[1]
Weighted Average Estimated Life	'20 years	[1]	'
Accumulated amortization	($5,501)		($5,765)
[1]	Primarily consists of customer relationships, customer lists, non-compete agreements and product formulas.

Exclusive_Brand_Licenses_Trade4

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Schedule Of Expected Amortization Expense) (Details) (USD $)	Sep. 30, 2013
In Millions, unless otherwise specified
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]	'
Amortization expense, Remainder of 2014	$14.40
Amortization expense, 2015	18.7
Amortization expense, 2016	18
Amortization expense, 2017	16.6
Amortization expense, 2018	$16.50

Other_Payables_And_Accrued_Exp2

Other Payables And Accrued Expenses (Details) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Other Payables And Accrued Expenses [Abstract]	'	'
Accrued advertising, promotion and royalties	$36,696	$12,605
Accrued employee-related benefits	16,972	26,668
Accrued value added taxes	12,561	6,395
Accrued interest	1,700	6,200
Other accruals	53,535	38,311
Total other payables and accrued expenses	$121,464	$90,179

ShortTerm_Debt_Details

Short-Term Debt (Details) (USD $)

3 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

Sep. 30, 2013

Jun. 30, 2013

Oct. 31, 2012

Sep. 30, 2012

Jan. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 02, 2013

Sep. 30, 2013

Jun. 30, 2013

Feb. 11, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 02, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 02, 2012

Jul. 02, 2012

Jul. 02, 2012

Jul. 02, 2013

Jul. 02, 2012

item

JPMorgan Chase Bank [Member]

Prime Rate Loans [Member]

LIBOR Loans [Member]

Second Lien Term Loan [Member]

Second Lien Term Loan [Member]

Second Lien Term Loan [Member]

Amended Second Lien Facility [Member]

Letters of Credit [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

LIBOR Rate [Member]

Base Rate [Member]

Requirements For PrePayment [Member]

Requirements For PrePayment [Member]

JPMorgan Chase Bank [Member]

Base Rate Loans [Member]

LIBOR Loans [Member]

Amended Second Lien Facility [Member]

Base Rate Loans [Member]

LIBOR Loans [Member]

Amended Second Lien Facility [Member]

Second Lien Term Loan [Member]

Amended Second Lien Facility [Member]

Second Lien Term Loan [Member]

Second Lien Term Loan [Member]

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility expiration date

'

'

'

'

'

1-Jan-16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revoling bank credit facility, current

'

'

'

'

'

$300,000,000

'

'

'

'

'

'

$25,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility, maximum

'

'

'

'

'

375,000,000

'

'

'

30,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum borrowing capacity based on percentage of accounts receivable percentage

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum borrowing capacity based on percentage of inventory percentage

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount by which borrowing base may be temporarily increased

'

'

25,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit facility debt service coverage ratio

1.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Average borrowing base capacity minimum covenant trigger threshold

25,000,000

'

'

'

35,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Basis spread on variable rate

'

'

'

'

'

'

0.25%

1.75%

'

'

'

'

'

'

1.00%

2.50%

'

'

0.25%

1.75%

'

3.25%

1.75%

'

'

Applicable margin of borrowing

'

'

25,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Borrowing base in effect

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Commitment fee percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

'

'

0.38%

0.38%

'

'

0.25%

'

'

'

'

Weighted average interest rate

2.10%

'

'

2.30%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit, amount outstanding

234,200,000

88,000,000

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letters of credit outstanding

3,200,000

2,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remaining borrowing capacity

$76,800,000

'

'

'

'

'

'

'

'

'

'

$35,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Term loan maturity date

'

'

'

'

'

'

'

'

2-Jul-14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Prepayment, potential start date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1-Feb-13

'

Length of measurement period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'30 days

Commitments_And_Contingencies_

Commitments And Contingencies (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Mar. 31, 2013	Jun. 30, 2013
Debt Instrument [Line Items]	'	'	'
Period for achievement of specified sales targets for acquired brands.	'3 years	'	'
Payment of first installment	'	$5	'
Payment of second installment	5	'	'
Investment in Elizabeth Arden Salon Holdings	'	'	7.6
Additonal amount to be invested in Elizabeth Arden Salon Holdings	2.1	'	'
Term that Elizabeth Arden Salon Holdings is measured for to determine price	'12 months	'	'
Proposed increase to taxable income for Fiscal 2008 and Fiscal 2009	29.1	'	'
2% Secured Convertible Debt [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Debt instrument, stated interest rate	2.00%	'	'
Maximum [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Additional amount to be invested in Give Back Brands subject to achievement of specific sales targets	28	'	'
Federal [Member] | Unfavorably Resolved Examination [Member]	'	'	'
Debt Instrument [Line Items]	'	'	'
Operating loss carryforwards	'	'	105
Operating loss carryforwards, amount available to offset any cash flow impact	'	'	$60

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (USD $)	3 Months Ended
	Sep. 30, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Aggregate principle amount	$250,000,000
Debt instrument, maturity	1-Mar-21
7 3/8% Senior Notes [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Debt instrument, stated interest rate	7.38%

Fair_Value_Measurements_Schedu

Fair Value Measurements (Schedule Of Estimated Fair Values Of Long Term Debt) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Jun. 30, 2013
		7 3/8% Senior Notes [Member]	Level 2 [Member]	Level 2 [Member]
			7 3/8% Senior Notes [Member]	7 3/8% Senior Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'
7 3/8% Senior Notes due	'	'	$270,000	$271,250
Debt instrument, stated interest rate	'	7.38%	'	'
Debt instrument, maturity	1-Mar-21	'	'	'

Fair_Value_Measurements_Schedu1

Fair Value Measurements (Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis) (Details) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Asset	$523	$658
Liability	1,421	'
Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Asset	523	658
Liability	$1,421	'

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Narrative) (Details)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

USD ($)

USD ($)

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Minimum [Member]

Maximum [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Currency Contracts [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

USD ($)

USD ($)

EUR (€)

GBP (£)

Currency Contracts [Member]

Currency Contracts [Member]

USD ($)

USD ($)

AUD

CAD

CHF

Currency Contracts [Member]

Currency Contracts [Member]

Derivative [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term foreign currency cash flow hedges are hedged

'

'

'

'

'

'

'12 months

'24 months

'

'

'

'

'

'

'12 months

'

'24 months

Maturity of foreign currency cash flow hedges

'

'

'

'

'

'

31-Oct-13

31-May-15

'

'

'

'

'

31-Oct-13

'

31-May-14

'

Amount recorded resulting from hedge ineffectiveness relating to foreign currency contracts

'

'

$0

$0

'

'

'

'

$0

$0

'

'

'

'

'

'

'

Derivative, notional amount

'

'

'

'

19,300,000

20,300,000

'

'

'

'

12,100,000

4,600,000

9,600,000

'

'

'

'

Selling, general and administrative expense, foreign currency contracts (credit) charge

($700,000)

($500,000)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative_Financial_Instrumen3

Derivative Financial Instruments (Schedule Of Foreign Exchange Contracts And The Gains (Losses) Associated With The Settlement Of Contracts) (Details) (USD $)	Sep. 30, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Derivative Financial Instruments [Abstract]	'	'
Other assets	$523	$658
Other payables	$1,421	'

Derivative_Financial_Instrumen4

Derivative Financial Instruments (Gain (Loss) Reclassified From Accumulated Other Comprehensive Income Into Income, Effective Portion) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013		Sep. 30, 2012
Derivative Instruments, Gain (Loss) [Line Items]	'		'
Gain (Loss) Recognized on Derivatives in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)	$100	[1]	($152)	[1]
Tax expense (benefit)	13		-47
Sales [Member] | Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
Gain (Loss) Recognized on Derivatives in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)	56	[2]	-3	[2]
Cost Of Sales [Member] | Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
Gain (Loss) Recognized on Derivatives in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)	7	[3]	-96	[3]
Selling, General and Administrative Expenses [Member] | Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
Gain (Loss) Recognized on Derivatives in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)	$37	[4]	($53)	[4]
[1]	Net of tax expense of $13 for the three months ended September 30, 2013 and tax benefit of $47 for the three months ended September 30, 2012.
[2]	Recorded in net sales on the consolidated statements of income.
[3]	Recorded in cost of sales on the consolidated statements of income.
[4]	Recorded in selling, general and administrative expenses on consolidated statements of income.

Derivative_Financial_Instrumen5

Derivative Financial Instruments (Net Loss Recognized On Derivatives In Other Comprehensive Income, Net Of Tax, Effective Portion) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013		Sep. 30, 2012
Derivative Instruments, Gain (Loss) [Line Items]	'		'
(Loss) Gain Reclassified from Accumulated Other Comprehensive Income (Loss) into Income, Effective Portion	($1,467)	[1]	($519)	[1]
Tax benefit	202		131
Sales [Member] | Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
(Loss) Gain Reclassified from Accumulated Other Comprehensive Income (Loss) into Income, Effective Portion	-1,685		-680
Cost Of Sales [Member] | Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
(Loss) Gain Reclassified from Accumulated Other Comprehensive Income (Loss) into Income, Effective Portion	-101		-283
Selling, General and Administrative Expenses [Member] | Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
(Loss) Gain Reclassified from Accumulated Other Comprehensive Income (Loss) into Income, Effective Portion	$319		$444
[1]	Net of tax benefits of $202 and $131 for the three months ended September 30, 2013 and 2012, respectively.

Repurchases_Of_Common_Stock_De

Repurchases Of Common Stock (Details) (USD $)	3 Months Ended
	Sep. 30, 2013	Jun. 30, 2013
Equity, Class of Treasury Stock [Line Items]	'	'
Common stock repurchased, shares	4,831,602	4,686,094
Cost of common stock repurchased	$92,830,000	$87,776,000
Repurchase of common stock	5,054,000	'
Common Stock Repurchase Program [Member]	'	'
Equity, Class of Treasury Stock [Line Items]	'	'
Stock repurchase program, authorized amount	120,000,000	'
Common stock repurchased, shares	4,507,603	'
Average price of common stock repurchased	$18.85	'
Cost of common stock repurchased	85,000,000	'
Stock repurchase program, remaining amount	35,000,000	'
Treasury Method [Member]	'	'
Equity, Class of Treasury Stock [Line Items]	'	'
Common stock repurchased, shares	145,508	'
Average price of common stock repurchased	$34.74	'
Cost of common stock repurchased	$5,100,000	'

Segment_Data_And_Related_Infor2

Segment Data And Related Information (Narrative) (Details)	3 Months Ended
	Sep. 30, 2013
	segment
Segment Reporting Information [Line Items]	'
Number of operating segments	2
International [Member]	'
Segment Reporting Information [Line Items]	'
Number of countries company operates in	120

Segment_Data_And_Related_Infor3

Segment Data And Related Information (Comparative Summary Of Net Sales And Segment Profit (Loss) By Operating Segment) (Details) (USD $)	3 Months Ended
	Sep. 30, 2013		Sep. 30, 2012
Segment Reporting Information [Line Items]	'		'
Net Sales	$343,609,000		$344,541,000
Profit (Loss)	20,945,000		31,570,000
Depreciation and Amortization	12,529,000		10,660,000
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	2,002,000		2,665,000
Interest Expense, net	6,032,000		6,198,000
Consolidation and Elimination Adjustments	-1,993,000		453,000
Unallocated Corporate Expenses	2,375,000	[1]	11,594,000	[2]
Income before income taxes	2,002,000		2,665,000
Restructuring expenses	1,800,000		'
Transition costs related to restructuring	600,000		'
Inventory related costs	195,504,000		197,142,000
North America [Member]	'		'
Segment Reporting Information [Line Items]	'		'
Net Sales	224,659,000		231,557,000
Profit (Loss)	28,887,000		36,808,000
International [Member]	'		'
Segment Reporting Information [Line Items]	'		'
Net Sales	118,950,000		112,984,000
Profit (Loss)	-7,942,000		-5,238,000
New Wave And Give Back Brands [Member]	'		'
Segment Reporting Information [Line Items]	'		'
Inventory related costs	'		$11,600,000
[1]	Amounts for the three months ended September 30, 2013, include $1.8 million of restructuring expenses and $0.6 million of related transition costs incurred with respect to sales and other positions across various business units that are being eliminated to derive expense savings and additional operating efficiencies.
[2]	Amounts for the three months ended September 30, 2012, include $11.6 million of inventory-related costs primarily for inventory purchased by the Company from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition expenses.